CVE-2015-4523
Blue Coat Malware Analysis Appliance (MAA) before 4.2.5 and Malware Analyzer G2 allow remote attackers to bypass a virtual machine protection mechanism and consequently write to arbitrary files, cause a denial of service (host reboot or reset to factory…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (4.47%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Blue Coat Malware Analysis Appliance (MAA) before 4.2.5 and Malware Analyzer G2 allow remote attackers to bypass a virtual machine protection mechanism and consequently write to arbitrary files, cause a denial of service (host reboot or reset to factory defaults), or execute arbitrary code via vectors related to saving files during analysis.
- CVSS 3.0
- 9.3 CRITICALCVSS:3.0/AV:L/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
- EPSS
- 4.47% probability · 91th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-264
- Affected
- symantec/malware analysis appliance · symantec/malware analyzer g2
- Source
- cve@mitre.org
References
- https://bto.bluecoat.com/security-advisory/sa97Third Party Advisory
- https://bto.bluecoat.com/security-advisory/sa97Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.